BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 63107)

  • 1. Prediction of fetal outcome by urinary estriol, maternal serum placental lactogen, and alpha-fetoprotein in diabetes and hepatosis of pregnancy.
    Garoff L
    Obstet Gynecol; 1976 Dec; 48(6):659-66. PubMed ID: 63107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential determination of serum human placental lactogen, estriol, and estetrol for assessment of fetal morbidity.
    Kundu N; Carmody PJ; Didolkar SM; Petersen LP
    Obstet Gynecol; 1978 Nov; 52(5):513-20. PubMed ID: 724167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxemia of pregnancy: assessment of fetal distress by urinary estriol and circulating human placental lactogen and alpha-fetoprotein levels.
    Garoff L; Seppälä M
    Am J Obstet Gynecol; 1976 Dec; 126(8):1027-33. PubMed ID: 63245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of postterm pregnancies with maternal serum placental lactogen and alpha-fetoprotein concentrations.
    Josimovich JB; Soffronoff P; Starkovsky N; Mueller-Heubach E
    Obstet Gynecol; 1977 Oct; 50(4):445-9. PubMed ID: 71669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal serum HPL levels in normal and complicated pregnancy as an index of placental function.
    Ylikorkala O
    Acta Obstet Gynecol Scand Suppl; 1973; 26():1-52. PubMed ID: 4522254
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary oestriol and serum activities of human placental lactogen and heat stable alkaline phosphatase as indicators of fetoplacental function.
    Karjalainen O; Stenman U; Widholm O
    Ann Chir Gynaecol Fenn; 1975; 64(1):50-4. PubMed ID: 1155905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estriol and human placental lactogen as risk indicators in pregnancies of diabetic and hypertensive patients].
    Günter HH; Berger L; Messner U; Niesert S
    Z Geburtshilfe Neonatol; 1995; 199(4):142-7. PubMed ID: 7497015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of fetal alcohol syndrome by maternal alpha fetoprotein, human placental lactogen and pregnancy specific beta 1-glycoprotein.
    Halmesmäki E; Autti I; Granström ML; Heikinheimo M; Raivio KO; Ylikorkala O
    Alcohol Alcohol Suppl; 1987; 1():473-6. PubMed ID: 2447904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of fetuses in the late pregnancy by serial determinations of serum human placental lactogen levels].
    Kaibara M; Marumoto Y; Taniguchi I; Kobayashi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Oct; 34(10):1724-8. PubMed ID: 7175278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alpha feto protein. Normal pregnancies and maternal diseases. Apropos of 3,010 radioimmunologic determinations].
    Brettes JP; Tourne CE; Gandar R
    J Gynecol Obstet Biol Reprod (Paris); 1976; 5(5):637-44. PubMed ID: 61982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma hormone assay in pregnancy.
    Branconi F; Cariati E; Cappelli G; Paladini S; Scarselli G
    Int J Biol Res Pregnancy; 1981; 2(3):146-8. PubMed ID: 6174457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental function, fetal distress, and the fetal/placental weight ratio in normal and gestotic pregnancies.
    Riss P; Bartl W
    Int J Biol Res Pregnancy; 1982; 3(1):10-3. PubMed ID: 7200464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monitoring of HPL, estriol and estetrol in high-risk pregnancy].
    Gherzi R; Pastore M; Labate D
    Minerva Ginecol; 1981 Oct; 33(10):911-6. PubMed ID: 7312213
    [No Abstract]   [Full Text] [Related]  

  • 14. [Alpha-fetoprotein, HPL, ostriol and SP1 concentrations in prostaglandin-induced mid-trimester abortions (author's transl)].
    Cornely M; Schumann K; Völker W; Weitzel H
    Geburtshilfe Frauenheilkd; 1978 Jun; 38(6):446-51. PubMed ID: 78872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary estriols in diabetic pregnancy: a reappraisal.
    Dooley SL; Depp R; Socol ML; Tamura RK; Vaisrub N
    Obstet Gynecol; 1984 Oct; 64(4):469-75. PubMed ID: 6384843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine assessment of high-risk pregnancies.
    Petersen LP; Kundu N
    Obstet Gynecol Annu; 1980; 9():169-94. PubMed ID: 6773003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alpha fetoprotein in maternal blood during normal and pathological pregnancies].
    Gilles G; Debruche ML; Gaspard U; Franchimont P
    C R Seances Soc Biol Fil; 1977; 171(3):696-702. PubMed ID: 71941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human placental lactogen and chorionic gonadotropin in diabetic pregnancies (author's transl)].
    Artner J; Baumung H; Ogris E
    Wien Klin Wochenschr; 1977 Aug; 89(15):524-31. PubMed ID: 899030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alpha-1 fetoprotein in maternal serum (author's transl)].
    Melchert F
    Geburtshilfe Frauenheilkd; 1975 Mar; 35(3):173-6. PubMed ID: 48489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The determination of human placental lactogen (HPL) for hormonal supervision in late pregnancy].
    Nieder J; Kapitza W
    Zentralbl Gynakol; 1976; 98(18):1129-36. PubMed ID: 983489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.